Bristol-Myers Squibb Announces Dividend Increase

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a 3.1 percent increase in the company’s quarterly dividend, beginning in the first quarter of 2011.

The dividend increase will result in a quarterly dividend of thirty-three cents ($0.33) per share on the $.10 par value Common Stock of the corporation for an indicative 2011 full-year dividend of $1.32 per share, subject to the normal quarterly review by the Board. The next quarterly dividend will be payable on February 1, 2011, to stockholders of record at the close of business on January 7, 2011.

The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 1, 2011, to stockholders of record at the close of business on February 4, 2011.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.



CONTACT:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
[email protected]
or
Investors:
John Elicker, 609-252-4611
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Other Health  Professional Services  Banking  Finance  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Monday, Bernstein analysts echoed what many were probably thinking about Novo Nordisk’s Rybselsus price: “Finally we can stop talking about it.”

Low interest rates and strong stock valuations are two top reasons why U.S. drugmakers are on the move for deals.

Despite a 45% premium offered to Allergan investors through the AbbVie buyout, one investor is suing to block the deal.